What Drove the Medicare Advantage Rate Increase
The Centers for Medicare and Medicaid Services (CMS) finalized a 2.48% payment rate increase for Medicare Advantage (MA) plans in 2027. This decision added an estimated $13 billion in additional annual revenue for health insurers participating in the program. Consequently, the announcement sent health insurer stocks sharply higher in after-hours trading.
Understanding the CMS Final Rule
Medicare Advantage is a privately administered alternative to traditional Medicare. Under this model, the government pays insurers a per-member, per-month fee to cover senior healthcare. CMS adjusts these rates annually based on expected medical costs, policy priorities, and enrollment trends. Therefore, any upward revision in rates translates directly into improved revenue outlook for MA insurers.
The 2027 rate hike marks a significant boost for an industry that has struggled recently with rising medical utilization among seniors and tightening profit margins. Furthermore, this increase arrives at a time when major insurers have been actively restructuring their MA plan portfolios to cut unprofitable offerings.
How Insurers Responded to the CMS Announcement
After the announcement, health insurer stocks rallied sharply. The three largest Medicare Advantage insurers — UnitedHealth Group, Humana, and CVS Health (through its Aetna division) — together cover nearly 60% of all Medicare Advantage enrollees nationwide. Accordingly, the rate hike carried outsized importance for all three companies.
Stock Market Reaction at a Glance
| Insurer | After-Hours Stock Gain |
|---|---|
| UnitedHealth Group (UNH) | +9.9% |
| Humana (HUM) | +13% |
| CVS Health (CVS) | +7.8% |
The gains reflected strong investor confidence that the rate increase would provide meaningful relief to MA business margins, which had been under pressure for several quarters.
UnitedHealth Group: Leading the Market Surge
UnitedHealth Group is the largest Medicare Advantage insurer in the United States. Its stock climbed nearly 10% in after-hours trading following the CMS announcement. This rally is especially notable given that UnitedHealth had faced headwinds recently, including higher-than-expected medical costs and underperformance in its MA star ratings for 2025.
Star Ratings and Bonus Payments
Medicare Advantage star ratings directly influence insurer revenue. Plans rated four stars or higher receive bonus payments from the government. Additionally, higher star scores generate larger rebates when insurers submit bids below CMS benchmarks. More than three-fourths of UnitedHealth’s over 8 million MA members are enrolled in plans with at least four stars — a result that has reassured investors.
Moreover, UnitedHealth has been trimming unprofitable MA plans for 2026 to sharpen its competitive focus. The new rate environment gives it additional financial breathing room to pursue that strategy.
Humana’s Big Gains and Strategic Position
Humana posted the strongest single-session gain among the top MA insurers, with shares rising 13% after hours. As the second-largest Medicare Advantage insurer, Humana has placed all its strategic bets on the MA market. Notably, the company divested its commercial health insurance business to concentrate entirely on Medicare Advantage and TRICARE plans.
Why the Rate Hike Matters Most to Humana
Because Humana relies almost exclusively on MA revenue, a favorable rate update from CMS has a direct and immediate impact on its financial outlook. However, the company has faced challenges. Its insurance division reported a loss of nearly $1 billion in the fourth quarter of 2025. Nevertheless, the finalized 2027 rate increase offers a credible path toward margin recovery.
In addition, Humana has been pursuing Medicare Advantage star ratings improvement through litigation, having refiled its star ratings lawsuit in mid-2025. A better rate environment strengthens its ability to invest in quality improvement initiatives.
CVS Health Rides the Medicare Wave
CVS Health, through its Aetna subsidiary, is the third-largest Medicare Advantage insurer in the country. Its stock rose 7.8% after hours following the CMS announcement. For CVS, the rate increase supports Aetna’s ongoing effort to stabilize its MA business after shedding hundreds of thousands of enrollees to improve its medical loss ratio.
Aetna’s Turnaround Strategy
Aetna had previously faced a sharp decline in its MA star ratings, followed by a recovery in 2023. Today, Aetna focuses on maintaining plan quality while managing cost ratios more efficiently. Therefore, the higher 2027 payment rate directly supports this turnaround strategy and reduces near-term financial pressure
What This Means for Medicare Beneficiaries
Higher government payments to insurers do not automatically translate into lower costs or better benefits for enrollees. However, a healthier financial environment for MA insurers does reduce the risk of plan exits — a trend that had been accelerating in recent years as margins declined. When insurers exit markets, beneficiaries face disruption and must find new coverage.
Key Beneficiary Considerations
- Plan continuity: Financially stable insurers are less likely to withdraw from counties or regions.
- Benefit preservation: Better payment rates may slow the erosion of supplemental benefits such as dental, vision, and over-the-counter allowances.
- Competition: A more attractive MA market encourages insurer participation, which can maintain competitive premiums for seniors.
The Road Ahead for Medicare Advantage Insurers
The 2.48% rate hike offers a much-needed tailwind for the MA industry. Still, structural challenges remain. Medical utilization among seniors continues to rise. Furthermore, CMS has pledged to increase the number of MA plan audits and expand its medical coding oversight workforce. Risk adjustment accuracy — and concerns about upcoding practices — will remain a focus of regulatory scrutiny.
Investors Watch the Long Game
For investors, the rate announcement delivers short-term relief. However, long-term profitability in Medicare Advantage depends on managing medical costs, maintaining star ratings, and navigating an evolving regulatory environment. All three major insurers — UnitedHealth, Humana, and CVS Health — now have a stronger foundation to pursue that balance heading into 2027.
